×
Jyong Biotech Price to Free Cash Flow Ratio 1970-1969 | MENS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Jyong Biotech price to free cash flow ratio from 1970 to 1969. Price to free cash flow ratio can be defined as
View More
Jyong Biotech Price to Free Cash Flow Ratio 1970-1969 | MENS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Jyong Biotech price to free cash flow ratio from 1970 to 1969. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$225.3B
Amgen (AMGN)
$164.8B
Gilead Sciences (GILD)
$144.5B
Vertex Pharmaceuticals (VRTX)
$120.6B
Bristol Myers Squibb (BMY)
$98.6B
CSL (CSLLY)
$85.4B
GSK (GSK)
$77.5B
Regeneron Pharmaceuticals (REGN)
$60.8B
Alnylam Pharmaceuticals (ALNY)
$42.9B
Argenex SE (ARGX)
$36.2B
BioNTech SE (BNTX)
$27.7B
Royalty Pharma (RPRX)
$20.6B
Insmed (INSM)
$19.7B
Biogen (BIIB)
$19.3B
Illumina (ILMN)
$17.3B
Genmab (GMAB)
$15B
Genmab (GNMSF)
$15B
Incyte (INCY)
$13.6B
Moderna (MRNA)
$13.2B
Exelixis (EXEL)
$12.4B
QIAGEN (QGEN)
$11.5B
BioMarin Pharmaceutical (BMRN)
$11.3B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10.2B
Bio-Techne Corp (TECH)
$9.2B
Exact Sciences (EXAS)
$9.1B
Verona Pharma American Depositary Share (VRNA)
$9B
Blueprint Medicines (BPMC)
$8.3B
Legend Biotech (LEGN)
$8B
Roivant Sciences (ROIV)
$7.9B